Metabolic markers of hypoxia: Systems biology application in biomedicine

Toxicology Mechanisms and Methods

Volumn 18, Issue 1, 2008, Pages 81-95

  Serkova, Natalie J ^a,c   Reisdorph, Nichole A ^b   Van Patot, Martha C Tissot ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^c Box B113 ^*  (United States)

Author keywords

Biomarkers; Chronic and Acute Hypoxia; Drug Toxicity; Mass Spectrometry; Metabolomics; NMR Spectroscopy; Proteomics

Indexed keywords

BIOLOGICAL MARKER;

ARTIFACT; ATHEROSCLEROSIS; BIOMEDICINE; BIOSTATISTICS; CARDIOVASCULAR DISEASE; CONGESTIVE CARDIOMYOPATHY; DNA SPLICING; ELECTRON SPIN RESONANCE; ELECTROSPRAY MASS SPECTROMETRY; ENVIRONMENTAL STRESS; GAS CHROMATOGRAPHY; GENE EXPRESSION; GENOMICS; HEART INFARCTION; HUMAN; HYPOXIA; INFRARED SPECTROSCOPY; ISCHEMIA; LIQUID CHROMATOGRAPHY; LUNG DISEASE; LUNG LAVAGE; MASS SPECTROMETRY; METABOLISM; METABOLOMICS; NEOPLASM; NEWBORN HYPOXIA; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEOMICS; PROTON NUCLEAR MAGNETIC RESONANCE; PULMONARY HYPERTENSION; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; SURGICAL STRESS; SYSTEMS BIOLOGY;

EID: 38549093441     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.1080/15376510701795769     Document Type: Review

References (92)

1. Adachi, J., Kumar, C., Zhang, Y., Olsen, J. V., and Mann, M. 2006. The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol. 7(9):R80.
2. Agarwal, V. R., Bulun, S. E., and Simpson, E. R. 1995. Quantitative detection of alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in aromatase-expressing human cells by competitive RT-PCR. Mol. Cell. Probes 9:453-464.
3. Anderson, L. 2005. Candidate-based proteomics in the search for biomarkers of cardiovascular disease. J. Physiol. (Lond). 563(Pt 1):23-60.
4. Asikainen, T. M., Chang, L. -Y., Coalson, J. J., Schneider, B. K., Waleh, N. S., Ikegami, M., Shannon, J. M., Winter, V. T., Grubb, P., Clyman, R. I., Yoder, B. A., Crapo, J. D., and White, C. W. 2006. Improved lung growth and function through hypoxia-inducible factor in primate chronic lung disease of prematurity. FASEB J. 20(10):1698-1700.
5. Bailey, D. M., Ainslie, P. N., Jackson, S. K., Richardson, R. S., and Ghatei, M. 2004a. Evidence against redox regulation of energy homoeostasis in humans at high altitude. Clin. Sci. (Colch). 107(6):589-600.
6. Bailey, D. M., Kleger, G. -R., Holzgraefe, M., Ballmer, P. E., and Bartsch, P. 2004b. Pathophysiological significance of peroxidative stress, neuronal damage, and membrane permeability in acute mountain sickness. J. Appl. Physiol. 96(4):1459-1463.
7. Bailey, D. M., Davies, B., Young, I. S., Hullin, D. A., and Seddon, P. S. 2001. A potential role for free radical-mediated skeletal muscle soreness in the pathophysiology of acute mountain sickness. Aviation Space Environ. Med. 72(6):513-521.
8. Bailey, D. M., Roukens, R., Knauth, M., Kallenberg, K., Christ, S., Mohr, A., Genius, J., Storch-Hagenlocher, B., Meisel, F., McEneny, J., Young, I. S., Steiner, T., Hess, K., and Bartsch, P. 2006. Free radical-mediated damage to barrier function is not associated with altered brain morphology in high-altitude headache. J. Cereb. Blood Flow Metab. 26(1):99-111.
9. Baillie, J. K., Bates, M. G. D., Thompson, A. A. R., Waring, W. S., Partridge, R. W., Schnopp, M. F., Simpson, A., Gulliver-Sloan, F., Maxwell, S. R. J., and Webb, D. J. 2007. Endogenous urate production augments plasma antioxidant capacity in healthy lowland subjects exposed to high altitude. Chest 131(5):1473-1478.
10. Barr, J. R., Maggio, V. L., Patterson, D. G. Jr., Cooper, G. R., Henderson, L. O., Turner, W. E., Smith, S. J., Hannon, W. H., Needham, L. L., and Sampson, E. J. 1996. Isotope dilution-mass spectrometric quantification of specific proteins: model application with apolipoprotein A-I. Clin. Chem. 42(10):1676-1682.
11. Biomarkers Definitions Working Group. 2001. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69(3):89-95.
12. Bowler, R. P., Ellison, M. C., and Reisdorph, N. 2006. Proteomics in pulmonary medicine. Chest 130(2):567-574.
13. Brindle, J. T., Antti, H., Holmes, E., Tranter, G., Nicholson, J. K., Bethell, H. W. L., Clarke, S., Schofield, P. M., McKilligin, E., Mosedale, D. E., and Grainger, D. J. 2002. Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics [erratum appears in Nat. Med. 2003;9(4):477]. Nat. Med. 8(12):1439-1444.
14. Caulum, M. M., Murphy, B. M., Ramsay, L. M., and Henry, C. S. 2007. Detection of cardiac biomarkers using micellar electrokinetic chromatography and a cleavable tag immunoassay. Anal. Chem. 79(14):5249-5256.
15. Dolt, K. S., Karar, J., Mishra, M. K., Salim, J., Kumar, R., Grover, S. K., and Qadar Pasha, M. A. 2007. Transcriptional downregulation of sterol metabolism genes in murine liver exposed to acute hypobaric hypoxia. Biochem. Biophys. Res. Commun. 354(1):148-153.
16. Douglas, R. M., Miyasaka, N., Takahashi, K., Latuszek-Barrantes, A., Haddad, G. G., and Hetherington, H. P. 2007. Chronic intermittent but not constant hypoxia decreases NAA/Cr ratios in neonatal mouse hippocampus and thalamus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292(3):R1254-1259.
17. Droma, Y., Hanaoka, M., Basnyat, B., Arjyal, A., Neupane, P., Pandit, A., Sharma, D., Miwa, N., Ito, M., Katsuyama, Y., Ota, M., and Kubo, K. 2006. Genetic contribution of the endothelial nitric oxide synthase gene to high altitude adaptation in sherpas. High Altitude Med. Biol. 7(3):209-220.
18. Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R., Harris, M. H., Plas, D. R., Zhuang, H., Cinalli, R. M., Alavi, A., Rudin, C. M., and Thompson, C. B. 2004. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res. 64(11):3892-3899.
19. Farber, H. W., and Barnett, H. F. 1991. Differences in prostaglandin metabolism in cultured aortic and pulmonary arterial endothelial cells exposed to acute and chronic hypoxia. Circ. Res. 68(5):1446-1457.
20. Fiehn, O. 2001. Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks. Compar. Funct. Genom. 2:155-168.
21. Foerch, C., Curdt, I., Yan, B., Dvorak, F., Hermans, M., Berkefeld, J., Raabe, A., Neumann-Haefelin, T., Steinmetz, H., and Sitzer, M. 2006. Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke. J. Neurol. Neurosurg. Psychiatry 77(2):181-184.
22. Fyles, A., Milosevic, M., Hedley, D., Pintilie, M., Levin, W., Manchul, L., and Hill, R. P. 2002. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J. Clin. Oncol. 20(3):680-687.
23. Gelfi, C., De Palma, S., Ripamonti, M., Eberini, I., Wait, R., Bajracharya, A., Marconi, C., Schneider, A., Hoppeler, H., and Cerretelli, P. 2004. New aspects of altitude adaptation in Tibetans: a proteomic approach. FASEB J. 18(3):612-614.
24. Gika, H. G., Theodoridis, G. A., Wingate, J. E., and Wilson, I. D. 2007. Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine. J. Proteome Res. 6(8):3291-3303.
25. Graven, K. K., and Farber, H. W. 1998. Endothelial cell hypoxic stress proteins. J. Lab. Clin. Med. 132(6):456-463.
26. Graven, K. K., McDonald, R. J., and Farber, H. W. 1998. Hypoxic regulation of endothelial glyceraldehyde-3-phosphate dehydrogenase. Am. J. Physiol. 274(2 Pt 1):C347-355.
27. Griffin, J. L. 2004. Metabolic profiles to define the genome: can we hear the phenotypes?. Philos. Trans. R. Soc. Lond. B Biol. Sci. 359(1446):857-871.
28. Griffin, J. L., and Shockcor, J. P. 2004. Metabolic profiles of cancer cells. Nat. Rev. Drug Discov. Cancer 4(7):551-561.
29. Grover, R. F., Reeves, J. T., Will, D. H., and Blount, S. G. 1963. Pulmonary vasoconstriction in steers at high altitude. J. Appl. Physiol. 18:567-574.
30. Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F., Gelb, M. H., and Aebersold, R. 1999. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17(10):994-999.
31. Harrigan, G. G., Brackett, D. J., and Boros, L. G. 2005. Medicinal chemistry, metabolic profiling and drug target discovery: a role for metabolic profiling in reverse pharmacology and chemical genetics. Mini Rev. Med. Chem. 5(1):13-20.
32. Harvey, P. J., Gready, J. E., Yin, Z., and McLean, A. J. 2000. Acute oxygen supplementation restores markers of hepatocyte energy status and hypoxia in cirrhotic rats. J. Pharmacol. Exp. Ther. 293(2):641-645.
33. Hirsch, J., Hansen, K. C., Burlingame, A. L., and Matthay, M. A. 2004. Proteomics: current techniques and potential applications to lung disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 287(1):L1-23.
34. Hochachka, P. W., and Storey, K. B. 1975. Metabolic consequences of diving in animals and man. Science. 187(4177):613-621.
35. Holmes, E., and Antti, H. 2002. Chemometric contributions to the evolution of metabonomics: mathematical solutions to characterising and interpreting complex biological NMR spectra. Analyst 127(12):1549-1557.
36. Hoshikawa, Y., Nana-Sinkam, P., Moore, M. D., Sotto-Santiago, S., Phang, T., Keith, R. L., Morris, K. G., Kondo, T., Tuder, R. M., Voelkel, N. F., and Geraci, M. W. 2003. Hypoxia induces different genes in the lungs of rats compared with mice [erratum appears in Physiol. Genomics 2003;13(1):79]. Physiol. Genomics 12(3):209-219.
37. Hultschig, C., Kreutzberger, J., Seitz, H., Konthur, Z., Bussow, K., and Lehrach, H. 2006. Recent advances of protein microarrays. Curr. Opin. Chem. Biol. 10(1):4-10.
38. Hung, T. H., Skepper, J. N., and Burton, G. J. 2001. In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. Am. J. Pathol. 159(3):1031-1043.
39. Irwin, D. C., Tissot van Patot, M. C., Tucker, A., and Bowen, R. 2005. Direct ANP inhibition of hypoxia-induced inflammatory pathways in pulmonary microvascular and macrovascular endothelial monolayers. Am. J. Physiol. Lung Cell. Mol. Physiol. 288(5):L849-859.
40. Jefferson, J. A., Simoni, J., Escudero, E., Hurtado, M. -E., Swenson, E. R., Wesson, D. E., Schreiner, G. F., Schoene, R. B., Johnson, R. J., and Hurtado, A. 2004. Increased oxidative stress following acute and chronic high altitude exposure. High Altitude Med. Biol. 5(1):61-69.
41. Kasiganesan, H., Sridharan, V., and Wright, G. 2007. Prolyl hydroxylase inhibitor treatment confers whole-animal hypoxia tolerance. Acta Physiol. (Oxf). 190(2):163-169.
42. Kirby, J., Heath, P. R., Shaw, P. J., and Hamdy, F. C. 2007. Gene expression assays. Adv. Clin. Chem. 44:247-292.
43. Kuhn, E., Wu, J., Karl, J., Liao, H., Zolg, W., and Guild, B. 2004. Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards. Proteomics 4(4):1175-1186.
44. Kulshreshtha, R., Ferracin, M., Wojcik, S. E., Garzon, R., Alder, H., Agosto-Perez, F. J., Davuluri, R., Liu, C. -G., Croce, C. M., Negrini, M., Calin, G. A., and Ivan, M. 2007. A microRNA signature of hypoxia. Mol. Cell. Biol. 27(5):1859-1867.
45. Kumar, G. K., and Klein, J. B. 2004. Analysis of expression and posttranslational modification of proteins during hypoxia. J. Appl. Physiol. 96(3):1178-1186.discussion 1170-1172
46. Leach, R. M., Sheehan, D. W., Chacko, V. P., and Sylvester, J. T. 1998. Effects of hypoxia on energy state and pH in resting pulmonary and femoral arterial smooth muscles. Am. J. Physiol. 275(6 Pt 1):L1051-1060.
47. Lee, K., Roth, R. A., and LaPres, J. J. 2007. Hypoxia, drug therapy and toxicity. Pharmacol. Ther. 113(2):229-246.
48. Lynch, J. R., Blessing, R., White, W. D., Grocott, H. P., Newman, M. F., and Laskowitz, D. T. 2004. Novel diagnostic test for acute stroke. Stroke 35(1):57-63.
49. Magagnin, M. G., Sergeant, K., Van Den Beucken, T., Rouschop, K. M. A., Jutten, B., Seigneuric, R., Lambin, P., Devreese, B., Koritzinsky, M., and Wouters, B. G. 2007. Proteomic analysis of gene expression following hypoxia and reoxygenation reveals proteins involved in the recovery from endoplasmic reticulum and oxidative stress. Radiother. Oncol. 83(3):340-345.
50. Maiti, P., Singh, S. B., Sharma, A. K., Muthuraju, S., Banerjee, P. K., and Ilavazhagan, G. 2006. Hypobaric hypoxia induces oxidative stress in rat brain. Neurochem. Int. 49(8):709-716.
51. Mikuriya, K., Kuramitsu, Y., Ryozawa, S., Fujimoto, M., Mori, S., Oka, M., Hamano, K., Okita, K., Sakaida, I., and Nakamura, K. 2007. Expression of glycolytic enzymes is increased in pancreatic cancerous tissues as evidenced by proteomic profiling by two-dimensional electrophoresis and liquid chromatography-mass spectrometry/mass spectrometry. Int. J. Oncol. 30(4):849-855.
52. Montaner, J. 2006. Stroke biomarkers: can they help us to guide stroke thrombolysis?. Drug News Perspect. 19(9):523-532.
53. Nicholson, J. K., Lindon, J. C., and Holmes, E. 1999. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29(11):1181-1189.
54. Nicholson, J. K., and Wilson, I. D. 2003. Opinion: understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nat. Rev. Drug Discov. Drug Discovery 2(8):668-676.
55. Niemann, C. U., Choi, S., Behrends, M., Hirose, R., Noh, J., Coatney, J. L., Roberts, J. P., Serkova, N. J., and Maher, J. J. 2006. Mild hypothermia protects obese rats from fulminant hepatic necrosis induced by ischemia-reperfusion. Surgery 140(3):404-412.
56. Niemann, C. U., Hirose, R., Liu, T., Behrends, M., Brown, J. L., Kominsky, D. F., Roberts, J. P., and Serkova, N. 2005. Ischemic preconditioning improves energy state and transplantation survival in obese Zucker rat livers. Anesth. Analg. 101(6):1577-1583.
57. Niemann, C. U., Saeed, M., Akbari, H., Jacobsen, W., Benet, L. Z., Christians, U., and Serkova, N. 2002. Close association between the reduction in myocardial energy metabolism and infarct size: dose-response assessment of cyclosporine. J. Pharmacol. Exp. Ther. 302(3):1123-1128.
58. Nordsmark, M., Alsner, J., Keller, J., Nielsen, O. S., Jensen, O. M., Horsman, M. R., and Overgaard, J. 2001. Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations. Br. J. Cancer 84(8):1070-1075.
59. Ommen, S. R. 2005. There is much more to the recipe than just outflow obstruction [comment]. J. Am. Coll. Cardiol. 46(8):1551-1552.
60. Pan, X., Tan, N., Zeng, G., Zhang, Y., and Jia, R. 2005. Amentoflavone and its derivatives as novel natural inhibitors of human Cathepsin B. Bioorg. Med. Chem. 13(20):5819-5825.
61. Parekh, S. B., Bubb, W. A., Hunt, N. H., and Rae, C. 2006. Brain metabolic markers reflect susceptibility status in cytokine gene knockout mice with murine cerebral malaria. Int. J. Parasitol. 36(13):1409-1418.
62. Park, Y., Hirose, R., Coatney, J. L., Ferrell, L., Behrends, M., Roberts, J. P., Serkova, N. J., and Niemann, C. U. 2007. Ischemia-reperfusion injury is more severe in older versus young rat livers. J. Surg. Res. 137(1):96-102.
63. Pelczer, I. 2005. High-resolution NMR for metabomics. Curr. Opin. Drug Discov. Devel. 8:127-133.
64. Pialoux, V., Mounier, R., Ponsot, E., Rock, E., Mazur, A., Dufour, S., Richard, R., Richalet, J. P., Coudert, J., and Fellmann, N. 2006. Effects of exercise and training in hypoxia on antioxidant/pro-oxidant balance. Eur. J. Clin. Nutr. 60(12):1345-1354.
65. Plymoth, A., Lofdahl, C. -G., Ekberg-Jansson, A., Dahlback, M., Broberg, P., Foster, M., Fehniger, T. E., and Marko-Varga, G. 2007. Protein expression patterns associated with progression of chronic obstructive pulmonary disease in bronchoalveolar lavage of smokers. Clin. Chem. 53(4):636-644.
66. Ramirez, J. -M., Folkow, L. P., and Blix, A. S. 2007. Hypoxia tolerance in mammals and birds: from the wilderness to the clinic. Annu. Rev. Physiol. 69:113-143.
67. Rudin, M., Beckmann, N., Porszasz, R., Reese, T., Bochelen, D., and Sauter, A. 1999. In vivo magnetic resonance methods in pharmaceutical research: current status and perspectives. NMR Biomed. 12(2):69-97.
68. Sabatine, M. S., Liu, E., Morrow, D. A., Heller, E., McCarroll, R., Wiegand, R., Berriz, G. F., Roth, F. P., and Gerszten, R. E. 2005. Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation 112(25):3868-3875.
69. Serkova, N., Bendrick-Peart, J., Alexander, B., and Tissot van Patot, M. C. 2003. Metabolite concentrations in human placentae and their changes due to the collection time after delivery. Placenta 24:227-235.
70. Serkova, N., Brand, A., Christians, U., and Leibfritz, D. 1996. Evaluation of the effects of immunosuppressants on neuronal and glial cells in vitro by multinuclear magnetic resonance spectroscopy. Biochim. Biophys. Acta 1314(1-2):93-104.
71. Serkova, N., Donohoe, P., Gottschalk, S., Hainz, C., Niemann, C. U., Bickler, P. E., Litt, L., Benet, L. Z., Leibfritz, D., and Christians, U. 2002. Comparison of the effects of cyclosporin a on the metabolism of perfused rat brain slices during normoxia and hypoxia. J. Cereb. Blood Flow Metab. 22(3):342-352.
72. Serkova, N., Fuller, T. F., Klawitter, J., Freise, C. E., and Niemann, C. U. 2005. H-NMR-based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants. Kidney Int. 67(3):1142-1151.
73. Serkova, N., and Niemann, C. U. 2007. Biochemical mechanisms of nephrotoxicity: application for metabolomics. Expert Opin. Drug Metab. Toxicol. 3(4):1-18.
74. Serkova, N., Rose, J. C., Epperson, L. E., Carey, H. V., and Martin, S. L. 2007. Quantitative analysis of liver metabolites in three stages of the circannual hibernation cycle in 13-lined ground squirrels by NMR. Physiol. Genomics 31:15-24.
75. Serkova, N. J., and Glunde, K. 2007. Metabolomics of cancer. Meth. Mol. Biol.In press
76. Serkova, N. J., and Niemann, C. U. 2006. Pattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics. Expert Rev. Mol. Diagn. 6(5):717-731.
77. Shaw, R. J. 2006. Glucose metabolism and cancer. Curr. Opin. Cell Biol. 18:598-608.
78. Stockwin, L. H., Blonder, J., Bumke, M. A., Lucas, D. A., Chan, K. C., Conrads, T. P., Issaq, H. J., Veenstra, T. D., Newton, D. L., and Rybak, S. M. 2006. Proteomic analysis of plasma membrane from hypoxia-adapted malignant melanoma. J. Proteome Res. 5(11):2996-3007.
79. Storey, K. B. 2006a. Gene hunting in hypoxia and exercise. Adv. Exp. Med. Biol. 588:293-309.
80. Storey, K. B. 2006b. Genomic and proteomic approaches in comparative biochemistry and physiology. Physiol. Biochem. Zool. 79(2):324-332.
81. Tanaseanu, C., Tudor, S., Tamsulea, I., Marta, D., Manea, G., and Moldoveanu, E. 2007. Vascular endothelial growth factor, lipoprotein-associated phospholipase A2, sP-selectin and antiphospholipid antibodies, biological markers with prognostic value in pulmonary hypertension associated with chronic obstructive pulmonary disease and systemic lupus erythematosus. Eur. J. Med. Res. 12(4):145-151.
82. Thongboonkerd, V. 2005. Genomics, proteomics and integrative "omics" in hypertension research. Curr. Opin. Nephrol. Hypertens. 14(2):133-139.
83. Tomes, L., Emberley, E., Niu, Y., Troup, S., Pastorek, J., Strange, K., Harris, A., and Watson, P. H. 2003. Necrosis and hypoxia in invasive breast carcinoma. Breast Cancer Res. Treat. 81(1):61-69.
84. Want, E. J., Nordstrom, A., Morita, H., and Siuzdak, G. 2007. From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics. J. Proteome Res. 6(2):459-468.
85. Want, E. J., O'Maille, G., Smith, C. A., Brandon, T. R., Uritboonthai, W., Qin, C., Trauger, S. A., and Siuzdak, G. 2006. Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry. Anal. Chem. 78(3):743-752.
86. White, M. Y., and Van Eyk, J. E. 2007. Cardiovascular proteomics: past, present, and future. Mol. Diagn. Ther. 11(2):83-95.
87. Williams, R. E., Major, H., Lock, E. A., Lenz, E. M., and Wilson, I. D. 2005. D-Serine-induced nephrotoxicity: a HPLC-TOF/MS-based metabonomics approach. Toxicology 207(2):179-190.
88. Wishart, D. S. 2005. Metabolomics: the principles and potential applications to transplantation. Am. J. Transplant 5(12):2814-2820.
89. Wishart, D. S., Tzur, D., Knox, C., Eisner, R., Guo, A. C., Young, N., Cheng, D., Jewell, K., Arndt, D., Sawhney, S., Fung, C., Nikolai, L., Lewis, M., Coutouly, M., Forsythe, I., Tang, P., Shrivastava, S., Jeroncic, K., Stothard, P., Amegbey, G., Block, D., Hau, D. D., Wagner, J., Miniaci, J., Clements, M., Gebremedhin, M., Guo, N., Zhang, Y., Duggan, G. E., Macinnis, G. D., Weljie, A. M., Dowlatabadi, R., Bamforth, F., Clive, D., Greiner, R., Li, L., Marrie, T., Sykes, B. D., Vogel, H. J., and Querengesser, L. 2007. HMDB: the Human Metabolome Database. Nucleic Acids Res. 35(Database issue):D521-526.
90. Wright, M. E., Han, D. K., and Aebersold, R. 2005. Mass spectrometry-based expression profiling of clinical prostate cancer. Mol. Cell Proteomics 4(4):545-554.
91. Yap, I. K., Clayton, T. A., Tang, H., Everett, J. R., Hanton, G., Provost, J., Charuel, C., Lindon, J. C., and Nicholson, J. K. 2006. An integrated metabonomic approach to describe temporal metabolic dysregulation induced in the rat by the model hepatotoxin allyl formate. J. Proteome Res. 5(10):2675-2684.
92. Zimmerman, L. H., Levine, R. A., and Farber, H. W. 1991. Hypoxia induces a specific set of stress proteins in cultured endothelial cells. J. Clin. Invest. 87(3):908-914.